Takeda's Response to COVID-19 If you were diagnosed with COVID-19 and have recovered, you may be able to help in furthering research into a potential therapy for others by donating your plasma.

Guided Search

Enter the condition you are interested in

Next

Find a Trial

Click for Guided SearchOpen Guided Search
Condition or Trial Identifier
Location

FILTERS

FILTERS (1)

Clear all

FILTERS (1)

Clear all
Medical Condition / Disease  
Drug / Treatment  
Trial Status  
Age

or Select Age Range:

Trial Type  
Phase  
Trial Identifier  
Results  
Show Results

Results

(1885)
Selected Filters
New York City, New York
Recruiting
From 12 years

Hemophilia A

ADYNOVATE Drug Use-Results Survey
6,240 miles (10,042 km) from
New York City, New York
From 12 years
Recruiting
From 18 years

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP
341 miles (549 km) from
New York City, New York
From 18 years
Recruiting
From 18 years

Acquired Hemophilia A

Prospective and Retrospective, Non-interventional Study to Evaluate the Safety and Effectiveness of Obizur in Real-life Practice
400 miles (644 km) from
New York City, New York
From 18 years
Recruiting
All Ages

Hemophilia B

RIXUBIS PMS India (RIXUBIS PMS)
7,849 miles (12,632 km) from
New York City, New York
All Ages years
Recruiting
From 18 years

Chronic Inflammatory Demyelinating Polyradiculoneuropathy

Phase III Efficacy, Safety, and Tolerability Study of HYQVIA/HyQvia and GAMMAGARD LIQUID/KIOVIG in CIDP
1.48 miles (2.38 km) from
New York City, New York
From 18 years
Recruiting
Up to 5 years

Hemophilia A

Safety, Immunogenicity and Hemostatic Efficacy of PEGylated Recombinant FVIII (BAX 855) in Previously Untreated Patients (PUPs) < 6 Years of Age With Severe Hemophilia A
1.39 miles (2.24 km) from
New York City, New York
Up to 5 years
Recruiting
18 - 65 years

Hemophilia A or B With Inhibitors

FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)
4,288 miles (6,901 km) from
New York City, New York
18 - 65 years
Recruiting
All Ages

Hemophilia A

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)
331 miles (533 km) from
New York City, New York
All Ages years
Recruiting
All Ages

Congenital thrombotic thrombocytopenic purpura

A Study of Prophylactic and On-demand Treatment of Congenital Thrombotic Thrombocytopenic Purpura (cTTP) With BAX 930 (rADAMTS13)
424 miles (683 km) from
New York City, New York
All Ages years
Recruiting
All Ages

Hemophilia A

A Post Marketing Surveillance Study for ADYNOVATE in South Korea
6,863 miles (11,044 km) from
New York City, New York
All Ages years